All past events from CeBIL

• 

  23 Oct. 2020, 9:00

  Nordic Network for Research in Biomedical Law Conference (online)

  Join biomedical and health law researchers to discuss the most pressing current issues in patient care, healthcare, regulation and research in the Nordics

• 

  2 June 2020, 14:00-17:00

  INAMRSS/CeBIL Webinar Social Science Responses to Antimicrobial Resistance and COVID-19: New experiences to be gained and mutual lessons to be learned

  Leading international AMR experts will explore the social science dimensions of antimicrobial resistance and the COVID-19 pandemic

• 

  8 May 2020, 8:30

  CeBIL co-organizes 2020 Petrie-Flom Center Conference at Harvard Law School

  Innovation and Protection: The Future of Medical Device Regulation.

• 

  27 Apr. 2020, 9:00

  CeBIL co-organizes The International Regulators’ Roundtable on Artificial Intelligence Technologies in Health Care at Harvard Law School

  Efforts, initiatives and challenges around the globe

• 

  20 Feb. 2020, 16:00-17:00

  Social Media Platforms as Public Health Arbiters: The Ethical and Legal Implications of Facebook's Suicide Detection Algorithm

  Michael Lowery Wilson will talk on the ethical, cultural and jurisdictional landscape of medical surveillance as it pertains to
  suicidal behavior and offer an opportunity to discuss the wider ramifications on society as a whole

• 

  6 Nov. 2019, 8:00

  How much is too much - Excessive Pharmaceutical Prices in European Competition Law & Regulation

  Join the debate on excessive pricing of pharmaceuticals!

• 

  6 Sept. 2019

  CeBIL Annual Symposium 2019: Legal Innovation to Support the Development of Antimicrobial Drugs

  This symposium explores the complex interactions between law and antimicrobial research and development

• 

  12 June 2019, 8:30

  CeBIL – RIBS Symposium: At the Cutting Edge: New Developments in the Law of Biomedicine

  Symposium aims to address contemporaneous issues emerging in the field of biomedicine

• 

  27 May 2019, 9:00

  Governing Health 4.0: Legal and Ethical Considerations – US-European Perspectives

  Five international scholars from a multidisciplinary background will share their insights and debate on this topic.

• 

  8 May 2019, 12:00-13:00

  Regulatory and intellectual property aspects of orphan drug innovation

  What are the possibilities and hindrances in the European IPR and regulatory system for the continued development of orphan drugs?